<DOC>
	<DOCNO>NCT00568828</DOCNO>
	<brief_summary>Earlier investigation detect low level macular pigment ( MP ) center fovea halo MP high eccentricity person type 2 idiopathic juxtafoveal teleangiectasia ( MACTEL ) [ Helb H-M , Charbel Issa P , Pauleikhoff D , Scholl HPN , Holz FG , MacTel-Study Group . Macular Pigment Density Distribution Patients Macular Telangiectasia . ARVO Annual Meeting 2006 , Fort Lauderdale , 30.04.-5.05.2006 . Program # 5701/B795 ] . To date know whether total MP reduce MACTEL whether even MP accumulate high eccenticities compare healthy probands . With suggested study aim 1. investigate Lutein Zeaxanthin serum level MACTEL probands 2. investigate quantify MP posterior pole MACTEL probands 3. detect possible change MP concentration distribution follow supplementation Lutein Zeaxanthin</brief_summary>
	<brief_title>MPOD Macular Teleangiectasia Following Supplementation Lutein Zeaxanthin</brief_title>
	<detailed_description>Rationale performing study Earlier investigation detect low level macular pigment ( MP ) center fovea halo MP high eccentricity person type 2 idiopathic juxtafoveal teleangiectasia ( MACTEL ) [ Helb H-M , Charbel Issa P , Pauleikhoff D , Scholl HPN , Holz FG , MacTel-Study Group . Macular Pigment Density Distribution Patients Macular Telangiectasia . ARVO Annual Meeting 2006 , Fort Lauderdale , 30.04.-5.05.2006 . Program # 5701/B795 ] . To date know whether total MP reduce MACTEL whether even MP accumulate high eccenticities compare healthy probands . With suggested study aim 1. investigate Lutein Zeaxanthin serum level MACTEL probands 2. investigate quantify MP posterior pole MACTEL probands 3. detect possible change MP concentration distribution follow supplementation Lutein Zeaxanthin The suggested study During study plan select least 10 MACTEL probands different pattern MP distribution include 1. detectable accumulation MP center segmental reduction MP temporally 2. nearly central accumulation large area reduce MP temporally 3. detectable accumulation MP center halo MP eccentric location These probands supplement Lutein ( L ) Zeaxanthin ( Z ) ( 12mg L 1 mg Z , provide ester , 120mg Vitamin C , 17.6 mg Vitamin E , 10mg Zink , 40µg Selen ( Ocuvite Lutein™ ) ) duration nine month . During supplementation three month stop supplementation , probands investigate every three month include 1. ophthalmologic investigation , 2. fundus photography , 3. measurement MP modify Heidelberg retina Angiograph employ two excitation wavelength ( 514 488nm ) 4. measurement L Z serum . Aim study 1 . Investigation change MP concentration distribution follow supplementation L Z MACTEl probands 2 . How serum level L Z change probands ? Visit : V1 Screening &amp; Start supplementat V2 V3 V4 End supplemenation V5 stop intake Months 0 3 6 9 12 general Informed consent X Medical history X in- exclusion criterion X concommitant medication X X X X X Adverse event X X X X Pill count X X X Vital signs/ BMI X X Slitlamp investigation X X X X X Fundusphotography X X Visual acuity X X X X X Supplementation X X X Measurement Xanthophylls Eye : MPOD ( HRA ) X X X X X Food frequency questionnaire X X Blood collection For ( Heparin ) Plasma quantify Xanthophylls Lipids X X X X X Probands resident within perimeter 40km around clinic preferentially select low travel expense . Recruitment takles place regular visit course MACTEL study . For angiography vein punctated additional punction need . Serum ist centrifuge 1500g 15min keep -70°C analyse . Analyse Xanthophylls Lipids serum perform central laboratory University Münster . Autofluorescence image part study protocol MACTEL Study . Two main image take , one excitation wavelength 488nm ( good absorption MP ) one 514nm ( poor absorption MP ) . The digital subtration image provide map MP density around fovea . Inclusion criterion Informed consent Age least 18y. ? Type 2 IMT ? Healthy general condition ? At least one eye free lens- retina problem interfere MP measurement modofied Heidelberg retina angiograph ? Exclusion criteria No informed consent ? Younger al 18 y. ? Intake Supplements contain L Z ( &gt; 3mg L und &gt; 1mg Z ) last 6 month ? Bad general condition/ unintended loss weight ( &gt; 10 % ) within last 3 monhs ?</detailed_description>
	<criteria>Different distribution macular pigment patient know macular teleangiectasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Macular Teleangiectasia</keyword>
	<keyword>Macular Pigment</keyword>
</DOC>